U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40
| | | | | | |

U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40

On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…

Vertex announced U.S. FDA approval for KALYDECOï¾® to treat eligible Infants withcystic fibrosis ages 1 month and older

-First and only CFTR modulator approved for this age group-
|

Vertex announced U.S. FDA approval for KALYDECOï¾® to treat eligible Infants withcystic fibrosis ages 1 month and older -First and only CFTR modulator approved for this age group-

On May 3, 2023, Vertex announced the Food and Drug Administration (FDA) ha approved KALYDECOï¾® (ivacaftor) for use…